Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
LMFA04000043 19(20) DiHDPA cPLA2i 1.0 BCD110605C28 1.19 pmol/ml medium
LMFA04000043 19(20) DiHDPA cPLA2i 1.0 BCD110605C30 1.14 pmol/ml medium
LMFA04000043 19(20) DiHDPA cPLA2i 1.0 BCD110605C29 1.07 pmol/ml medium
LMFA04000043 19(20) DiHDPA cPLA2i 20.0 BCD110605C64 1.32 pmol/ml medium
LMFA04000043 19(20) DiHDPA cPLA2i 20.0 BCD110605C66 1.22 pmol/ml medium
LMFA04000043 19(20) DiHDPA cPLA2i 20.0 BCD110605C65 1.24 pmol/ml medium
LMFA04000043 19(20) DiHDPA PLDi 1.0 BCD110605C16 0.785 pmol/ml medium
LMFA04000043 19(20) DiHDPA PLDi 1.0 BCD110605C17 0.741 pmol/ml medium
LMFA04000043 19(20) DiHDPA PLDi 1.0 BCD110605C18 0.727 pmol/ml medium
LMFA04000043 19(20) DiHDPA PLDi 20.0 BCD110605C54 1.38 pmol/ml medium
LMFA04000043 19(20) DiHDPA PLDi 20.0 BCD110605C52 1.6 pmol/ml medium
LMFA04000043 19(20) DiHDPA PLDi 20.0 BCD110605C53 1.44 pmol/ml medium
LMFA04000043 19(20) DiHDPA KDO+cPLA2i 1.0 BCD110605C32 1.27 pmol/ml medium
LMFA04000043 19(20) DiHDPA KDO+cPLA2i 1.0 BCD110605C31 1.07 pmol/ml medium
LMFA04000043 19(20) DiHDPA KDO+cPLA2i 1.0 BCD110605C33 1.1 pmol/ml medium
LMFA04000043 19(20) DiHDPA KDO+cPLA2i 20.0 BCD110605C68 1.18 pmol/ml medium
LMFA04000043 19(20) DiHDPA KDO+cPLA2i 20.0 BCD110605C69 1.25 pmol/ml medium
LMFA04000043 19(20) DiHDPA KDO+cPLA2i 20.0 BCD110605C67 1.13 pmol/ml medium
LMFA04000043 19(20) DiHDPA KDO+PLDi 1.0 BCD110605C19 0.909 pmol/ml medium
LMFA04000043 19(20) DiHDPA KDO+PLDi 1.0 BCD110605C20 0.689 pmol/ml medium
LMFA04000043 19(20) DiHDPA KDO+PLDi 1.0 BCD110605C21 0.787 pmol/ml medium
LMFA04000043 19(20) DiHDPA KDO+PLDi 20.0 BCD110605C56 1.35 pmol/ml medium
LMFA04000043 19(20) DiHDPA KDO+PLDi 20.0 BCD110605C57 1.44 pmol/ml medium
LMFA04000043 19(20) DiHDPA KDO+PLDi 20.0 BCD110605C55 1.18 pmol/ml medium
LMFA04000043 19(20) DiHDPA KDO+ATP+cPLA2i 1.0 BCD110605C37 1.2 pmol/ml medium
LMFA04000043 19(20) DiHDPA KDO+ATP+cPLA2i 1.0 BCD110605C38 0.766 pmol/ml medium
LMFA04000043 19(20) DiHDPA KDO+ATP+cPLA2i 1.0 BCD110605C39 0.97 pmol/ml medium
LMFA04000043 19(20) DiHDPA KDO+ATP+cPLA2i 20.0 BCD110605C74 1.28 pmol/ml medium
LMFA04000043 19(20) DiHDPA KDO+ATP+cPLA2i 20.0 BCD110605C75 1.23 pmol/ml medium
LMFA04000043 19(20) DiHDPA KDO+ATP+cPLA2i 20.0 BCD110605C73 1.51 pmol/ml medium
LMFA04000043 19(20) DiHDPA KDO+ATP+PLDi 1.0 BCD110605C25 0.741 pmol/ml medium
LMFA04000043 19(20) DiHDPA KDO+ATP+PLDi 1.0 BCD110605C27 0.795 pmol/ml medium
LMFA04000043 19(20) DiHDPA KDO+ATP+PLDi 1.0 BCD110605C26 0.789 pmol/ml medium
LMFA04000043 19(20) DiHDPA KDO+ATP+PLDi 20.0 BCD110605C61 1.67 pmol/ml medium
LMFA04000043 19(20) DiHDPA KDO+ATP+PLDi 20.0 BCD110605C62 1.3 pmol/ml medium
LMFA04000043 19(20) DiHDPA KDO+ATP+PLDi 20.0 BCD110605C63 1.61 pmol/ml medium
LMFA04000043 19(20) DiHDPA KDO + ATP 1.0 BCD110605C15 0.693 pmol/ml medium
LMFA04000043 19(20) DiHDPA KDO + ATP 1.0 BCD110605C14 0.752 pmol/ml medium
LMFA04000043 19(20) DiHDPA KDO + ATP 1.0 BCD110605C13 0.684 pmol/ml medium
LMFA04000043 19(20) DiHDPA KDO + ATP 20.0 BCD110605C49 1.54 pmol/ml medium
LMFA04000043 19(20) DiHDPA KDO + ATP 20.0 BCD110605C50 1.5 pmol/ml medium
LMFA04000043 19(20) DiHDPA KDO + ATP 20.0 BCD110605C51 1.65 pmol/ml medium
LMFA04000043 19(20) DiHDPA KDO 1.0 BCD110605C08 0.716 pmol/ml medium
LMFA04000043 19(20) DiHDPA KDO 1.0 BCD110605C07 0.687 pmol/ml medium
LMFA04000043 19(20) DiHDPA KDO 1.0 BCD110605C09 0.697 pmol/ml medium
LMFA04000043 19(20) DiHDPA KDO 20.0 BCD110605C45 1.26 pmol/ml medium
LMFA04000043 19(20) DiHDPA KDO 20.0 BCD110605C44 1.21 pmol/ml medium
LMFA04000043 19(20) DiHDPA KDO 20.0 BCD110605C43 1.46 pmol/ml medium
LMFA04000043 19(20) DiHDPA C 0.0 BCD110605C03 0.854 pmol/ml medium
LMFA04000043 19(20) DiHDPA C 0.0 BCD110605C01 0.985 pmol/ml medium